Cd8 Tyrosine Hydroxylase

Tyrosine hydroxylase is the rate-limiting enzyme in catecholamine synthesis, and its presence in CD8-positive immune cells links neurotransmitter metabolism with cellular immunity. The enzyme converts L-tyrosine to L-DOPA using molecular oxygen, iron, and tetrahydrobiopterin, initiating production of dopamine and related catecholamines. Studying tyrosine hydroxylase in CD8 T cells helps researchers examine how immune cells generate or respond to neurochemical signals and how these signals may influence activation, communication, and immune regulation. This topic is relevant to neuroimmunology, where interactions between the nervous and immune systems inform research into inflammation, stress responses, and disease mechanisms.

Cd8 Tyrosine Hydroxylase - Related Videos

Education

JoVE Core - Cell Biology

Receptor Tyrosine Kinases

0 Views •

2025

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Research

JoVE Journal - Medicine

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

0 Views •

Cited by 6 •

2013

Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.

Nanoparticle-Based Enrichment and Expansion of Antigen-Specific CD8+ T Cells

0 Views •

2025

This video describes a protocol for isolating rare-antigen-specific CD8+ T cells using magnetic nanoparticle-based artificial antigen-presenting cells (aAPCs) functionalized with antigenic peptide-loaded MHC-Igs and anti-CD28 antibodies. Interaction of the aAPCs with CD8+ T cells specifically expressing the antigenic peptide-targeting T cell receptors, followed by their expansion in vitro, results in the enrichment and expansion of this CD8+ T cell population.

An Assay for Cell Cycle Analysis of Antigen-Specific CD8+ T Cells

0 Views •

2025

This video demonstrates an assay to analyze antigen-specific CD8+ T cells in different cell cycle stages. Fluorescently-labeled viable cells are selected using flow cytometry, and the cells in the different cell cycle stages are identified by their DNA content using antibodies against cell proliferation-associated nuclear protein and a nucleic acid stain.

An In Vitro Assay for Studying the Cytotoxicity of Pre-Activated CD8+ T Cells against Cancer Cells

0 Views •

2025

This video showcases an apoptosis assay in cancer cells induced by pre-activated effector T cells. By co-culturing these cells with cancer cells marked with fluorescent nuclei, a caspase-cleavable fluorogenic substrate is added. Apoptotic cancer cells will display a different color in their nuclei, leading to dual fluorescence. This dual fluorescence is indicative of cancer cells undergoing apoptosis.

View All Results

FAQs

Related Topics